High-throughput cell-based screen for chemicals that inhibit infection by simian virus 40 and human polyomaviruses

Journal of Virology

Volumn 83, Issue 11, 2009, Pages 5630-5639

  Goodwin, Edward C ^a   Atwood, Walter J ^b   DiMaio, Daniel ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELLAGIC ACID; PROTEIN E7; SPIPERONE; VIRUS VECTOR; ANTIVIRUS AGENT;

ARTICLE; BK VIRUS; CELL GROWTH; CELL SCREENING; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; JC VIRUS; LIFE CYCLE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; SIMIAN VIRUS 40; VIRUS REPLICATION; WILD TYPE; ANIMAL; CELL LINE; CELL SURVIVAL; CERCOPITHECUS; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG EFFECT; ENZYME SPECIFICITY; PHYSIOLOGY;

BK POLYOMAVIRUS; HUMAN PAPILLOMAVIRUS; JC POLYOMAVIRUS; POLYOMAVIRUS; PRIMATES; SIMIAN VIRUS 40;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COMBINATORIAL CHEMISTRY TECHNIQUES; HUMANS; MOLECULAR STRUCTURE; POLYOMAVIRIDAE; SIMIAN VIRUS 40; SUBSTRATE SPECIFICITY;

EID: 66149084071     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00203-09     Document Type: Article

References (36)

1. Allander, T., K. Andreasson, S. Gupta, A. Bjerkner, G. Bogdanovic, M. A. Persson, T. Dalianis, T. Ramqvist, and B. Andersson. 2007. Identification of a third human polyomavirus. J. Virol. 81:4130-4136. (Pubitemid 46586907)
2. Anderson, H. A., Y. Chen, and L. C. Norkin. 1996. Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol. Biol. Cell 7:1825-1834. (Pubitemid 26386733)
3. Barbanti-Brodano, G., S. Sabbioni, F. Martini, M. Negrini, A. Corralini, and M. Tognon. 2006. BK virus, JC virus, and simian virus 40 infection in humans, and association with human tumors. Adv. Exp. Med. Biol. 577:319-341.
4. Bohl, D. L., and D. C. Brennan. 2007. BK virus nephropathy and kidney transplantation. Clin. J. Am. Soc. Nephrol. 2(Suppl. 1):S36-S46.
5. DeFilippis, R. A., E. C. Goodwin, L. Wu, and D. DiMaio. 2003. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J. Virol. 77:1551-1563. (Pubitemid 36055574)
6. Dropulic, L. K., and R. J. Jones. 2008. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transpl. 41:11-18.
7. Eash, S., W. Querbes, and W. J. Atwood. 2004. Infection of Vero cells by BK virus is dependent on caveolae. J. Virol. 78:11583-11590. (Pubitemid 39390744)
8. Elphick, G. F., W. Querbes, J. A. Jordan, G. V. Gee, S. Eash, K. Manley, A. Dugan, M. Stanifer, A. Bhatnagar, W. K. Kroeze, B. L. Roth, and W. J. Atwood. 2004. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:1380-1383. (Pubitemid 39532516)
9. Feng, H., S. M., Y. Chang, and P. S. Moore. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1049-1050.
10. Garcea, R. L., and M. J. Imperiale. 2003. Minireview: simian virus 40 infection of humans. J. Virol. 77:5039-5045.
11. Gaynor, A. M., M. D. Nissen, D. M. Whiley, I. M. Mackay, S. B. Lambert, G. Wu, D. C. Brennan, G. A. Storch, T. P. Sloots, and D. Wang. 2007. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog. 3:e64.
12. Gerard, R. D., and Y. Gluzman. 1985. New host cell system for regulated simian virus 40 DNA replication. Mol. Cell. Biol. 5:3231-3240. (Pubitemid 16255091)
13. Goodwin, E. C., and D. DiMaio. 2000. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Natl. Acad. Sci. USA 97:12513-12518.
14. Goodwin, E. C., L. K. Naeger, D. E. Breiding, E. J. Androphy, and D. DiMaio. 1998. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines. J. Virol. 72:3925-3934. (Pubitemid 28188694)
15. Greber, U. F. 2002. Signalling in viral entry. Cell. Mol. Life Sci. 59:608-626. (Pubitemid 34457539)
16. Harris, H. E. 2008. Progressive multifocal leucoencephalopathy in a patient with systemic lupus erythematosus treated with rituximab. Rheumatology 47:224-225.
17. Hirsch, H. H., D. C. Brennan, C. B. Drachenberg, F. Ginevri, J. Gordon, A. P. Limaye, M. J. Mihatsch, V. Nickeleit, E. Ramos, P. Randhawa, R. Shapiro, J. Steiger, M. Suthanthiran, and J. Trofe. 2005. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79:1277-1286. (Pubitemid 40734783)
18. Hwang, E.-S., D. J. Riese III, J. Settleman, L. A. Nilson, J. Honig, S. Flynn, and D. DiMaio. 1993. Inhibition of cervical carcinoma cell line proliferation by introduction of a bovine papillomavirus regulatory gene. J. Virol. 67:3720-3729. (Pubitemid 23180692)
19. Jiang, M., J. R. Abend, B. Tsai, and M. J. Imperiale. 2009. Early events during BK virus entry and disassembly. J. Virol. 83:1350-1358.
20. Khalili, K., M. K. White, F. Lublin, P. Ferrante, and J. R. Berger. 2007. Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology 68:985-990. (Pubitemid 46569130)
21. Knowles, W. A. 2000. Propagation and assay of BK virus. Methods Mol. Biol. 165:19-31.
22. Kotwal, G. J. 2008. Genetic diversity-independent neutralization of pandemic viruses (e.g., HIV), potentially pandemic (e.g., H5N1 strain of influenza) and carcinogenic (e.g., HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs). Vaccine 26:3055-3058.
23. Lee, W.-H., and E. Langhoff. 2006. Polyomavirus in human cancer development. Adv. Exp. Med. Biol. 577:310-318.
24. Mischitelli, M., A. Bellizzi, E. Anzivino, D. Fioriti, R. Boldorini, U. Miglio, F. Chiarini, F. Di Monaco, and V. Pietropaolo. 2008. Complications post renal transplantation: literature focus on BK virus nephropathy and diagnostic tools actually available. Virol. J. 5:38.
25. Naeger, L. K., E. C. Goodwin, E.-S. Hwang, R. A. DeFilippis, H. Zhang, and D. DiMaio. 1999. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein. Cell Growth Differ. 10:413-422. (Pubitemid 29284183)
26. Pelkmans, L., J. Kartenbeck, and A. Helenius. 2001. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3:473-483. (Pubitemid 32422083)
27. Pho, M. T., A. Ashok, and W. J. Atwood. 2000. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J. Virol. 74:2288-2292. (Pubitemid 30091483)
28. Psyrri, A., R. A. DeFilippis, A. P. B. Edwards, K. E. Yates, L. Manuelidis, and D. DiMaio. 2004. Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells. Cancer Res. 64:3079-3086. (Pubitemid 38581407)
29. Querbes, W., B. A. O'Hara, G. Williams, and W. J. Atwood. 2006. Invasion of host cells by JC virus identifies a novel role for caveolae in endosomal sorting of noncaveolar ligands. J. Virol. 80:9402-9413. (Pubitemid 44435619)
30. Rinaldo, C. H., and H. H. Hirsch. 2007. Antivirals for the treatment of polyomavirus BK replication. Expert Rev. Anti-Infect. Ther. 5:110-115.
31. Robb, J. A., and R. G. Martin. 1972. Genetic analysis of simian virus 40. III. Characterization of a temperature sensitive mutant blocked at an early stage of productive infection in monkey cells. J. Virol. 9:956-968.
32. Schelhaas, M., J. Malmstrom, L. Pelkmans, J. Haugstetter, L. Ellgaard, K. Grunewald, and A. Helenius. 2007. Simian virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell 131:516-529. (Pubitemid 350017762)
33. Schweighardt, B., and W. J. Atwood. 2001. HIV type 1 infection of human astrocytes is restricted by inefficient viral entry. AIDS Res. Hum. Retrovir. 17:1133-1142. (Pubitemid 32881580)
34. Settleman, J., and D. DiMaio. 1988. Efficient transactivation and morphologic transformation by bovine papillomavirus genes expressed from a bovine papillomavirus/simian virus 40 recombinant virus. Proc. Natl. Acad. Sci. USA 85:9007-9011. (Pubitemid 19001834)
35. Vacante, D. A., R. Traub, and E. O. Major. 1989. Extension of JC virus host range to monkey cells by insertion of a simian virus 40 enhancer into the JC virus regulatory region. Virology 170:353-361. (Pubitemid 19162551)
36. Zhang, J.-H., T. D. Y. Chung, and K. R. Oldenburg. 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4:67-73. (Pubitemid 29278954)